Could This FDA Approval Create a Blockbuster Drug for AbbVie?

Could This FDA Approval Create a Blockbuster Drug for AbbVie?

Submitted by admin on January 2, 2022 - 11:36pm
Source: 
Motley Fool
News Tags: 
AbbVie
Rinvoq
FDA
psoriatic arthritis
Headline: 
Could This FDA Approval Create a Blockbuster Drug for AbbVie?
snippet: 
  • Rinvoq becomes available to a huge swath of psoriatic arthritis patients seeking a second-line treatment.
  • Some quick math shows this new indication will likely fall just short of $1 billion blockbuster status.
  • AbbVie still appears to be an undervalued, high-income play for investors.

Do Not Allow Advertisers to Use My Personal information